US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

21.34

+0.11000.52%

Post-market: 21.340.00000.00%19:30 EDT

Volume:571.85K

Turnover:12.30M

Market Cap:1.36B

PE:-9.11

High:22.12

Open:21.45

Low:21.13

Close:21.23

52wk High:28.00

52wk Low:6.91

Shares:63.60M

Float Shares:47.12M

Volume Ratio:0.62

T/O Rate:1.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3433

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.47

PE(LYR):-6.68

Loading ...

Overview Company News Filings

Jade Biosciences reports positive interim Phase 1 data for JADE101 in IgA nephropathy, targets Q12W dosing

Jade Biosciences to present interim Phase 1 healthy volunteer data for JADE101 in IgA nephropathy on June 1 webcast

Jade Biosciences’ JADE101 Trial Opens a New Front in IgA Nephropathy Investing

Guggenheim Sticks to Their Buy Rating for Jade Biosciences (JBIO)

Jade Biosciences Price Target Maintained With a $39.00/Share by BTIG

BRIEF-Jade Biosciences Announces First Participant Dosed In First-In-Human Phase 1 Clinical Trial Of Jade201

Jade Biosciences doses first participant in Phase 1 trial of autoimmune drug candidate JADE201

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of Jade201, a Novel Half-Life Extended Afucosylated Anti-Baff Receptor Monoclonal Antibody

THOMSON REUTERS

Jade Biosciences Doses First Patient in Phase 2 Study of Kidney Disease Therapy

MT Newswires Live

Jade Biosciences Announces First Participant Dosed in Phase 2 Juniper Clinical Trial of Jade101 in Iga Nephropathy

THOMSON REUTERS

Jade Biosciences Inc - Interim Data From Juniper Phase 2 Trial Expected in 2027

THOMSON REUTERS

BRIEF-Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC Filing

Jade Biosciences price target raised to $34 from $24 at Wedbush

Jade Biosciences Is Maintained at Outperform by Wedbush

Jade Biosciences Inc : Guggenheim Raises Target Price to $32 From $23

THOMSON REUTERS

Stock Track | Jade Biosciences Soars 5.45% Intraday on Analyst Price Target Hikes and Upcoming Pipeline Catalysts

Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target

Wedbush Raises Price Target on Jade Biosciences to $34 From $24, Maintains Outperform Rating

MT Newswires Live

Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach

Jade Biosciences files $600M mixed securities shelf

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/JBIO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":21.34,"timestamp":1787342400000,"preClose":21.23,"halted":0,"volume":571848,"hourTrading":{"tag":"盘后","latestPrice":21.34,"preClose":21.34,"latestTime":"19:30 EDT","volume":9942,"amount":212162.1825,"timestamp":1787355006539,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.005181347150259041,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"Market Closed","change":0.11,"latestTime":"08-21 16:00:00 EDT","open":21.45,"high":22.12,"low":21.13,"amount":12301888.105872,"amplitude":0.046632,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":21.23,"postHourTrading":{"tag":"盘后","latestPrice":21.34,"preClose":21.34,"latestTime":"19:30 EDT","volume":9942,"amount":212162.1825,"timestamp":1787355006539,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.621931658922853,"impliedVol":0.6247,"impliedVolPercentile":0.3586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":0.621931658922853,"shares":63597387,"dividePrice":0,"high":22.12,"amplitude":0.046632,"preClose":21.23,"low":21.13,"week52Low":6.91,"pbRate":"0.47","week52High":28,"institutionHeld":0,"latestPrice":21.34,"eps":-2.343303,"divideRate":0,"volume":571848,"delay":0,"ttmEps":-2.343303,"open":21.45,"prevYearClose":15.43,"prevWeekClose":24.71,"prevMonthClose":19.75,"prevQuarterClose":22.22,"fiveDayClose":24.71,"twentyDayClose":20.08,"sixtyDayClose":21.5,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781496000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-08-21","current":-9.106804,"percent":0.19375,"low":-10.392766,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"high":-2.319279,"avg":-5.800455,"sd":2.675082,"marketCap":1350172526},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526}],"updateTime":1787445983802},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640995516","title":"Jade Biosciences reports positive interim Phase 1 data for JADE101 in IgA nephropathy, targets Q12W dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995516","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640995516?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:02","pubTimestamp":1780311756,"startTime":"0","endTime":"0","summary":"Jade Biosciences disclosed positive interim Phase 1 results for JADE101 in IgA nephropathy; data will be presented at the ERA Congress in June 2026.The study showed rapid, sustained biomarker improvement with a safety profile consistent with the drug class, supporting a less frequent dosing approach.A Phase 2 trial in IgA nephropathy is underway with interim clinical readouts expected in 2027.A registrational Phase 3 trial is planned to start in the first half of 2027, pending FDA requirements.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL7NqK7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672265","title":"Jade Biosciences to present interim Phase 1 healthy volunteer data for JADE101 in IgA nephropathy on June 1 webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672265","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672265?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:05","pubTimestamp":1780085123,"startTime":"0","endTime":"0","summary":"Jade Biosciences scheduled a June 1, 2026, conference call to present interim Phase 1 healthy-volunteer results for JADE101.JADE101 is an anti-APRIL monoclonal antibody being developed for IgA nephropathy as a potentially differentiated, disease-modifying therapy.The interim readout is expected to guide dosing strategy and further shape the drug’s clinical profile ahead of later-stage development decisions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL9C10MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","IE00BN0W2V16.EUR","IE00BKPKM429.USD","SG9999014021.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4585","BK4539","NDAQ","SG9999014013.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","BK4588","LU2210150020.SGD","BK4139","LU0314104364.USD","SG9999014039.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639367977","title":"Jade Biosciences’ JADE101 Trial Opens a New Front in IgA Nephropathy Investing","url":"https://stock-news.laohu8.com/highlight/detail?id=2639367977","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639367977?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:33","pubTimestamp":1780072438,"startTime":"0","endTime":"0","summary":"Jade Biosciences, Inc. ($JBIO) announced an update on their ongoing clinical study. The Phase 2 JUNIPER study from Jade Biosciences, Inc. focuses o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-jade101-trial-opens-a-new-front-in-iga-nephropathy-investing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-jade101-trial-opens-a-new-front-in-iga-nephropathy-investing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688307","title":"Guggenheim Sticks to Their Buy Rating for Jade Biosciences (JBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688307","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688307?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:39","pubTimestamp":1779885547,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Vamil Divan reiterated a Buy rating on Jade Biosciences yesterday and set a price target of $32.00. The company’s shares closed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-jade-biosciences-jbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638350137","title":"Jade Biosciences Price Target Maintained With a $39.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2638350137","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638350137?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:36","pubTimestamp":1779878160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 06:36 ET (10:36 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638154098","title":"BRIEF-Jade Biosciences Announces First Participant Dosed In First-In-Human Phase 1 Clinical Trial Of Jade201","url":"https://stock-news.laohu8.com/highlight/detail?id=2638154098","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638154098?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:09","pubTimestamp":1779826164,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Announces First Participant Dosed In First-In-Human Phase 1 Clinical Trial Of Jade201May 26 (Reuters) - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES ANNOUNCES FIRST PARTICIPANT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA3GRWRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638540935","title":"Jade Biosciences doses first participant in Phase 1 trial of autoimmune drug candidate JADE201","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540935","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540935?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:09","pubTimestamp":1779826141,"startTime":"0","endTime":"0","summary":"Jade Biosciences dosed the first participant in a first-in-human Phase 1 trial of JADE201 in rheumatoid arthritis.Interim Phase 1 results have not been presented; readouts are expected in 2027.The study will evaluate whether JADE201 can show an acceptable safety profile with evidence of the intended B-cell effects.The 2027 data are expected to guide which autoimmune indications move forward, shaping portfolio focus and development spending.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLx1Jx8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","BK4139","SG9999014005.SGD","BK4539","NDAQ","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","JBIO","LU2095319765.USD","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638512540","title":"Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of Jade201, a Novel Half-Life Extended Afucosylated Anti-Baff Receptor Monoclonal Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2638512540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638512540?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:05","pubTimestamp":1779825900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA3GRWRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511831","title":"Jade Biosciences Doses First Patient in Phase 2 Study of Kidney Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511831","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511831?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:36","pubTimestamp":1779795404,"startTime":"0","endTime":"0","summary":"Jade Biosciences  has dosed the first participant in its phase 2 trial of experimental therapy, JADE101, for immunoglobulin A nephropathy, or IgAN, the drugmaker said Tuesday.IgAN is a chronic autoimmune kidney disease that can progress to kidney failure over time, often affecting younger patients.The open-label study will enroll about 30 participants and evaluate safety, tolerability, kidney function and protein levels in urine as markers of disease progression, the company said.Interim results are expected in 2027, it added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516994","title":"Jade Biosciences Announces First Participant Dosed in Phase 2 Juniper Clinical Trial of Jade101 in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516994?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA5JJSVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638162595","title":"Jade Biosciences Inc - Interim Data From Juniper Phase 2 Trial Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2638162595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638162595?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA5JJSVZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635058494","title":"BRIEF-Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058494","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058494?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:04","pubTimestamp":1778879043,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC FilingMay 15  - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES INC - PROSPECTUS FILED FOR RESALE OF UP TO 39,542,339 SHARES BY SELLING STOCKHOLDERS - SEC FILINGSource text: [ID:n0001193125-26-227051]Further company coverage: JBIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634239643","title":"Jade Biosciences price target raised to $34 from $24 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634239643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634239643?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:25","pubTimestamp":1778520316,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico raised the firm’s price target on Jade Biosciences (JBIO) to $34 from $24 and keeps an Outperform rating on the shares....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-34-from-24-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-34-from-24-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634228974","title":"Jade Biosciences Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634228974?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:31","pubTimestamp":1778502660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 08:31 ET (12:31 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634479578","title":"Jade Biosciences Inc : Guggenheim Raises Target Price to $32 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2634479578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634479578?lang=en_us&edition=fundamental","pubTime":"2026-05-11 12:02","pubTimestamp":1778472173,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41L1TU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120340917","title":"Stock Track | Jade Biosciences Soars 5.45% Intraday on Analyst Price Target Hikes and Upcoming Pipeline Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1120340917","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120340917?lang=en_us&edition=fundamental","pubTime":"2026-05-08 22:12","pubTimestamp":1778249523,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) stock soared 5.45% during intraday trading on Friday, following a series of positive analyst actions and outlooks for the company's pipeline.The surge comes after Wedbush...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633445293","title":"Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2633445293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633445293?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:55","pubTimestamp":1778248525,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Jade Biosciences today and set a price target of $24.00. Rami Katkhuda has given h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jade-biosciences-buy-rating-reiterated-on-strong-cash-runway-jade101-differentiation-and-unchanged-24-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jade-biosciences-buy-rating-reiterated-on-strong-cash-runway-jade101-differentiation-and-unchanged-24-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633245661","title":"Wedbush Raises Price Target on Jade Biosciences to $34 From $24, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2633245661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633245661?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:22","pubTimestamp":1778242942,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of Buy and mean price target of $24.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431524","title":"Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633431524?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:36","pubTimestamp":1778232985,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on JBIO stock, giving a Buy rating today. Matt Phipps has given his Buy ratin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-jade-biosciences-as-jade101-data-and-multi-asset-pipeline-catalysts-approach-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-jade-biosciences-as-jade101-data-and-multi-asset-pipeline-catalysts-approach-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633058151","title":"Jade Biosciences files $600M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2633058151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633058151?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:32","pubTimestamp":1778193132,"startTime":"0","endTime":"0","summary":"17:17 EDT Jade Biosciences (JBIO) files $600M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-files-600m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-files-600m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":122,"code":"91000000","status":"200"}]}}